福元医药：关于左甲状腺素钠片获得药品注册证书的公告

Core Viewpoint - The announcement indicates that Fuyuan Pharmaceutical has received the drug registration certificate for Levothyroxine Sodium Tablets, allowing the company to commence production of the drug [1] Company Summary - Fuyuan Pharmaceutical has been granted a drug registration certificate by the National Medical Products Administration for Levothyroxine Sodium Tablets, with a specification of 100μg [1]